Kawasaki disease: practical guidance on diagnosis and management

Area of Science:

• Pediatric rheumatology
• Cardiology
• Vascular inflammation

Background:

• Kawasaki disease (KD) is a leading cause of acquired heart disease in children.
• Delayed diagnosis and treatment increase the risk of coronary artery aneurysms (CAAs).
• Effective management strategies are essential to mitigate long-term cardiac sequelae.

Purpose of the Study:

• To provide updated guidance on the diagnosis of Kawasaki disease.
• To outline management strategies for KD, emphasizing timely intervention.
• To highlight critical scenarios requiring subspecialty consultation for high-risk patients.

Main Methods:

• Review of current literature and clinical guidelines.
• Consensus-based recommendations for KD diagnosis and management.
• Case-based scenarios illustrating complex presentations and treatment decisions.

Main Results:

• Early recognition of KD clinical criteria is paramount for prompt treatment initiation.
• Intravenous immunoglobulin (IVIG) and aspirin are primary therapies.
• Risk stratification for CAA development guides treatment intensity and monitoring.

Conclusions:

• Timely diagnosis and appropriate management of KD can significantly reduce the incidence of coronary artery abnormalities.
• Subspecialty consultation is vital in managing severe KD or those at high risk for CAAs.
• Adherence to practice guidelines ensures optimal outcomes for children with Kawasaki disease.